Cancer52 has launched a manifesto called ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...

Cancer52 is proud to share its Annual Review for the financial year 2022-2023. As ever it is a great opportunity to look back at what has...

Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...

Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...

We are incredibly pleased to present our Annual Review for the financial year 2021-2022. It covers the period following the COVID-19...

Cancer52 are pleased to launch our report - Taking Action on Inequalities in Rare and Less Common Cancers: Understanding the Issues – at...

From the start of the COVID-19 pandemic, we saw the incredible commitment of members in pulling out all the stops to meet the needs of...

Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...

Working with Keep up with Cancer[i] Cancer52 has published a new report which covers the impact of Covid-19 on people with rare and less...

With help from its member charities, Cancer52 ran a second survey of people with rare and less common cancers from early December 2020 to...